Clear 7°. Wind Chill: -11°. Wind: W 16 mph.
Loading advertisement…
Trending: Massive 100-vehicle pileup in Michigan as snowstorm moves across the country
HomeNewsNationalHealth ( Page 77)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

US FDA plans to accelerate biosimilar approvals, FT reports

(Reuters) -The U.S. Food and Drug Administration is preparing to speed up approvals for biosimilars, or generic versions of complex biological drugs, the Financial Times reported on Wednesday. The regulator is expected to reduce the number of human clinical studies required for certain biosimilars and ...
by

Lilly, Walmart launch first retail pick-up option for weight-loss drug

(Reuters) -Eli Lilly said on Wednesday it is partnering with Walmart to expand access to Lilly’s weight-loss drug Zepbound, which will be offered for pick-up at Walmart pharmacies nationwide by mid-November. Lilly and rival Novo Nordisk started offering vials at discounted prices on their ...
by

BridgeBio’s drug for rare calcium disorder meets late-stage study goals

(Reuters) -BridgeBio Pharma said on Wednesday that its experimental drug for a rare genetic condition that causes low blood calcium met all the main and secondary goals in a late-stage study, sending its shares up 9.1% in premarket trading. In a study involving 70 ...
by

GE HealthCare boosts 2025 profit view after strong US demand helps third quarter

(Reuters) -GE HealthCare Technologies raised its annual adjusted profit forecast and beat estimates for third-quarter results on Wednesday, powered by strong demand for its medical devices in the United States and the Europe, Middle East, and Africa region. Over the past couple of years, medical ...
by

Merck, Eisai discontinue late-stage study for liver cancer therapy

(Reuters) -Merck and Japan’s Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy to treat a type of liver cancer, after interim results showed the treatment was unlikely to improve overall survival. The study tested Merck’s blockbuster drug ...
by

Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion

(Reuters) -Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and future payments, strengthening the life science firm’s presence in digital health and clinical trial research. The deal includes an upfront payment of ...
Loading advertisement…
by

Centene raises annual outlook after surprise quarterly profit, shares rise

(Reuters) -Centene on Wednesday raised its annual earnings forecast after reporting a third-quarter surprise profit, helped by a low tax rate, sending its shares more than 10% higher in premarket trading. The company also recorded a non-cash goodwill impairment of $6.7 billion after a quantitative ...
by

CVS raises full-year forecast, takes $5.7 billion impairment charge on health clinics

By Amina Niasse NEW YORK (Reuters) -CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy MinuteClinics. The company, which operates one of the largest U.S. pharmacy chains, ...
by

Thermo Fisher nears $10 billion takeover of Clario, FT reports

(Reuters) -Medical equipment maker Thermo Fisher is nearing an all-cash takeover of U.S-based Clario in a deal that could value the clinical trial data management company at about $10 billion, the Financial Times reported on Tuesday.  Reuters could not immediately verify the report. The acquisition could ...
by

Germany to give more than $1 billion for Holocaust survivors’ home care in 2026

BERLIN (AP) — The organization that handles claims on behalf of Jews who suffered under the Nazis said Wednesday that Germany has agreed to extend another $1.076 billion (923.9 million euros) for Holocaust survivors ‘ home care around the globe for the coming year. The ...
by

GSK raises 2025 sales forecast after strong growth in specialty medicines

(Reuters) -GSK raised its 2025 sales and earnings expectations on Wednesday after third-quarter results beat forecasts, helped by double-digit growth for its HIV and cancer drugs. This is CEO Emma Walmsley’s last quarterly update before Luke Miels takes over in early 2026 to steer the ...
by

Dental implants maker Straumann’s organic sales rises in third quarter

By Cian Muenster and Bartosz Dabrowski (Reuters) -Swiss dental implant maker Straumann reported an 8.3% rise in third-quarter organic sales on Wednesday, slightly above market expectations, as growth in most Asia-Pacific markets and North America outweighed muted demand in China. Revenue climbed to 602.2 million Swiss ...
First Previous737475767778798081Next Last